FGF19 induces the cell cycle arrest at G2-phase in chondrocytes

Fibroblast growth factor 19 (FGF19) has appeared as a new possible avenue in the treatment of skeletal metabolic disorders. However, the role of FGF19 on cell cycle progression in skeletal system is poorly understood. Here we demonstrated that FGF19 had the ability to reduce the proliferation of cho...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Hao, Li, Jiazhou, Pi, Caixia, Guo, Daimo, Zhang, Demao, Zhou, Xuedong, Xie, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10349815/
https://www.ncbi.nlm.nih.gov/pubmed/37454120
http://dx.doi.org/10.1038/s41420-023-01543-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10349815/
https://www.ncbi.nlm.nih.gov/pubmed/37454120
http://dx.doi.org/10.1038/s41420-023-01543-6

Ejemplares similares